Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2013
10/16/2013CN101687006B Reconstituted surfactants having improved properties
10/16/2013CN101674814B Modified-release particles based on polyelectrolytes and active ingredients and pharmaceutical formulations containing these particles
10/16/2013CN101516353B Controlled release oral dosage formulations comprising a core and one or more barrier layers
10/15/2013US8558048 Stabilized protein crystals, formulations comprising them and methods of making them
10/15/2013US8558009 Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
10/15/2013US8557875 Gene transfer agent composition containing polyamidoamine dendron
10/15/2013US8557870 Methods of treatment utilizing topical emulsion-gel composition comprising diclofenac sodium
10/15/2013US8557861 Low oil emulsion compositions for delivering taxoids and other insoluble drugs
10/15/2013US8557851 Combinations of flupirtine and sodium channel inhibiting substances for treating pains
10/15/2013US8557799 Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy
10/15/2013US8557607 Magnetic nanoparticles
10/15/2013US8557515 Compositions and methods for cancer diagnosis and therapy
10/15/2013US8557382 Layer by layer modification of microcapsules with inorganic materials
10/15/2013US8557301 Oral rehydration composition
10/15/2013US8557300 Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
10/15/2013US8557294 Film coating for tablets and caplets
10/15/2013US8557293 Sunscreen compositions for application to plants
10/15/2013US8557292 Carrier nanoparticles and related compositions, methods and systems
10/15/2013US8557291 Abuse-deterrent pharmaceutical compositions of opioids and other drugs
10/15/2013US8557290 Multifunction nanoconjugates for imaging applications and targeted treatment
10/15/2013US8557289 Nanoparticle suitable for delivery of a biomolecule into or out of a membrane enclosed cell or cell organelle
10/15/2013US8557288 Hydrogel microparticle formation in aqueous solvent for biomedical applications
10/15/2013US8557287 Silicone gel composition and dispenser therefor
10/15/2013US8557286 Method for producing a water-insoluble amorphous or partially amorphous controlled release matrix
10/15/2013US8557285 Pharmaceutical compositions for the coordinated delivery of NSAIDs
10/15/2013US8557283 Controlled release formulations of levodopa and uses thereof
10/15/2013US8557282 Extended release compositions comprising as active compound venlafaxine hydrochloride
10/15/2013US8557281 Water-swellable polymers
10/15/2013US8557280 Stable pharmaceutical composition and methods of using same
10/15/2013US8557279 Transdermal therapeutic system with crystallization-inhibiting protective film (release liner)
10/15/2013US8557278 Devices and methods for the delivery of blood clotting materials to bleeding wounds
10/15/2013US8557277 Medical products including modified extracellular matrix materials
10/15/2013US8557276 Hair care solution forming a film protecting natural hair from gluing products
10/15/2013US8557273 Medical devices and methods including polymers having biologically active agents therein
10/15/2013US8557271 Drug depot implantable within a joint
10/15/2013US8557269 Paper tissue with high lotion transferability
10/15/2013US8557268 Pest control agent, method for manufacture of pest control agent, and method for pest control
10/15/2013US8557265 Use of a synergistic composition as a therapeutic agent of disinfectant
10/15/2013US8557262 Divinyl ether derivatives capable of releasing active aldehydes and ketones and methods of use for perfuming surfaces
10/15/2013US8557260 Composition comprising at least two different cycloalkylmethicones and use thereof
10/15/2013US8557259 Liquid preparation
10/15/2013US8557248 Methods and compositions for treating malaria
10/15/2013US8557235 Bone substitute compositions, methods of preparation and clinical applications
10/15/2013US8557231 Biodegradable poly(beta-amino esters) and uses thereof
10/15/2013US8557230 Cosmetic compositions containing block copolymers, tackifiers and shine enhancing agents
10/15/2013US8556553 Hybrid organic/inorganic chemical hybrid systems, including functionalized calcium phosphate hybrid systems, and a solid-state method for producing the same
10/15/2013CA2685350C Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents
10/15/2013CA2614085C Pharmaceutical dosage form based on an osmotic active ingredient release system comprising an active ingredient combination of nifedipine and/or nisoldipine and an angiotensin ii antagonist
10/15/2013CA2604327C Pharmaceutical aerosol composition
10/15/2013CA2598316C Polyoxyalkylene chain-containing lipid derivative and lipid film structure containing such derivative
10/15/2013CA2594127C Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
10/15/2013CA2566326C Peritoneal dialysis solution
10/15/2013CA2544344C Pharmaceutical formulations of a quinolone antibiotic containing flavouring substances with improved pharmaceutical properties
10/15/2013CA2516322C Glycosaminoglycan-dnase combination therapy
10/15/2013CA2511523C Pharmaceutical formulation with an insoluble active agent for pulmonary administration
10/15/2013CA2499550C Sequestering subunit and related compositions and methods
10/15/2013CA2463827C Methods and compositions for controlled release of bioactive compounds
10/10/2013WO2013152314A1 A facile method for making non-toxic biomedical compositions comprising hybrid metal-polymer microparticles
10/10/2013WO2013152227A1 Embelin-based delivery system for water-insoluble active agents
10/10/2013WO2013152092A1 Soluble microneedle arrays for buccal delivery of vaccines
10/10/2013WO2013152044A1 Use of pc-nsaids to treat and/or prevent pulmonary inflammation
10/10/2013WO2013151981A1 Ewing's sarcoma bifunctional shrna design
10/10/2013WO2013151774A1 Combination therapy with an anti - hyaluronan agent and a tumor - targeted taxane
10/10/2013WO2013151754A1 Ibuprofen solid oral dosage composition comprising a methacrylic acid copolymer
10/10/2013WO2013151744A1 Materials and methods for treatment of cystic fibrosis and for induction of ion secretion
10/10/2013WO2013151698A1 Methods for using cerium oxide nanoparticles to mitigate or protect against radiation injury
10/10/2013WO2013151682A1 Process for forming microbubbles with high oxygen content and uses thereof
10/10/2013WO2013151650A1 Neurophilic nanoparticles
10/10/2013WO2013151595A1 Improved adjuvant system for oral vaccine adminstration
10/10/2013WO2013151518A1 Capsule formulations comprising ceftibuten
10/10/2013WO2013151517A1 Tablet formulations comprising cefpodoxime proxetil and clavulanic acid
10/10/2013WO2013151516A1 Film tablet formulations comprising cefuroxime axetil and clavulanic acid
10/10/2013WO2013151341A1 Injectable composition comprising phosphatidylcholine and method for preparing thereof
10/10/2013WO2013151326A1 Method of preparing composition for delivering an anionic drug
10/10/2013WO2013151283A1 Iron oxide nanocomposite, magnetic resonance imaging t2 contrast medium comprising same, and method for manufacturing same
10/10/2013WO2013151082A1 Aqueous liquid beverage
10/10/2013WO2013150542A2 A transdermal patch for treatment of dementia or alzheimer type dementia
10/10/2013WO2013150331A1 Acid resistant banding solution for acid resistant two piece hard capsules
10/10/2013WO2013150322A1 Prasugrel-containing immediate release stable oral pharmaceutical compositions
10/10/2013WO2013150277A1 Ophthalmic therapy
10/10/2013WO2013150193A1 Microparticles and nanoparticles made up of hydrophobized polysaccharides and an alpha-cyclodextrine
10/10/2013WO2013150055A1 Solid oral pharmaceutical compositions for isoxazoline compounds
10/10/2013WO2013150052A1 Soft chewable pharmaceutical products
10/10/2013WO2013150032A1 A dopamine-agonist-containing transdermal application system
10/10/2013WO2013149987A1 Pharmaceutical formulations comprising ccr3 antagonists
10/10/2013WO2013149538A1 Pharmaceutical composition
10/10/2013WO2013108270A4 Curcumin coated magnetite nanoparticles for biomedical applications
10/10/2013WO2013103424A9 Silk-based multifunctional biomedical platform
10/10/2013WO2013100881A3 Combined pharmaceutical formulation containing diacerein
10/10/2013WO2013095319A3 Formulations of flurbiprofen and diacerein
10/10/2013WO2013095317A3 Pharmaceutical formulations of flurbiprofen and glucosamin
10/10/2013WO2013090842A3 Ophthalmic compositions comprising polyvinyl caprolactam - polyvinyl acetate - polyethylene glycol graft copolymers (soluplus)
10/10/2013WO2013080225A3 Novel parenteral controlled release formulations of nsaid's
10/10/2013WO2013054337A9 Extended release pharmaceutical compositions of fesoterodine
10/10/2013WO2013054178A9 Extended release pharmaceutical compositions containing carbamazepine
10/10/2013WO2012139485A8 Oral solid preparation of compound antituberculosis drug and preparation method thereof
10/10/2013WO2012091523A8 Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof
10/10/2013WO2012013967A3 New uses
10/10/2013US20130267916 Percutaneous absorption preparation containing rivastigmine
10/10/2013US20130267608 Solid, edible, chewable laxative composition
1 ... 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 ... 2991